-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOMARIN PHARMACEUTICAL INC - DISCONTINUES DEVELOPMENT OF BMN 349, ORAL THERAPEUTIC FOR ALPHA-1 ANTITRYPSIN DEFICIENCY (AATD) - SEC FILING

路透·12/22/2025 14:07:32

登录查看新闻详情